Revenue fell 20.1% YoY with a massive surge in gross losses.
Treatment segment gross margin collapsed to -36%.
Received NOV from Washington State Department of Ecology regarding non-compliance.
Management evaluating equity financing to supplement declining liquidity.
The Q1 2026 filing reveals a company at a crossroads, where massive theoretical capacity meets a precarious financial reality. Perma-Fix has successfully expanded its regulatory footprint and secured a significant project backlog, but it is currently unable to convert these wins into positive cash flow. The disconnect between the 'paper' capacity of the PFNWR permit and the actual throughput of the facility suggests a dangerous lag in execution that is draining the company's remaining liquidity. Investors are now faced with a binary outcome: either the Q2 ramp-up of the DFLAW program and the LLNL contract materialize rapidly enough to stabilize the balance sheet, or the company will be forced into dilutive equity financing or operational downsizing. The emergence of the Washington State NOV adds a layer of regulatory risk that could jeopardize the company's primary revenue engine just as it attempts to scale.